BioSpace News Archive

Deals

Element Biosciences Closes Acquisition of Loop Genomics

Element Biosciences, developer of a new and disruptive DNA sequencing platform, today announced that the company has closed its acquisition of Loop Genomics, a long-read solutions company that enables short-read sequencers to obtain long range information.

February 8, 2022

·

2 min read

BioMidwest

Mednet Announces New Discount for Research Organizations Conducting Cardiovascular Studies

In recognition of American Heart Month, Mednet, a healthcare technology company, announced a new program to support research organizations conducting any type of cardiovascular research.

February 8, 2022

·

3 min read

MYND Diagnostics Inc. Announces Participation in Approved Monash University (Australia) Government Funded $3 Million Clinical Trial

MYND Diagnostics Inc., a wholly-owned subsidiary of MYND Life Sciences (CSE: MYND) (OTC: MYNDF), is pleased to announce that the Company’s proprietary biomarker testing technology will be a pivotal component of a $3 million, Government of Australia funded clinical trial.

February 8, 2022

·

5 min read

Business

Samyang Biopharm USA Announces Appointment of Eun-Ju Ryu as New President

Samyang Biopharm USA, Inc. (https://us.samyangbiopharm.com) a global biotech subsidiary of the Samyang Holdings Corp. (https://samyangbiopharm.com/eng), announced today that Eun-Ju Ryu has been appointed President of Samyang Biopharm USA, end of Jan. 2022.

February 8, 2022

·

3 min read

Business

CHOC names new neurology medical director and Neuroscience Institute co-medical director

CHOC is thrilled to welcome Dr. John Crawford as its new Medical Director of Neurology and Co-Medical Director of the CHOC Neuroscience Institute.

February 8, 2022

·

2 min read

Business

Applied Cells Inc. Enters Collaborative Marketing Agreement with S2 Genomics Inc. to Provide a Powerful Tumor Biology Solution in Tissue Sample Preparation

Applied Cells today announced a joint marketing agreement with S2 Genomics to further the field of tumor biology.

February 8, 2022

·

2 min read

Business

eHealth, Inc. to Announce Fourth Quarter and Fiscal Year 2021 Earnings Results on March 1 at 8:30 a.m. Eastern Time

eHealth, Inc. (NASDAQ: EHTH), a leading private online health insurance marketplace, today announced that the company plans to release fourth quarter and fiscal year 2021 financial results on March 1, 2022.

February 8, 2022

·

1 min read

BioMidwest

Iterum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Feb 08, 2022

Iterum Therapeutics plc announced that it has granted a non-statutory share option to purchase an aggregate of 50,000 ordinary shares of the Company as an inducement to a newly hired employee.

February 8, 2022

·

2 min read

Shares for Interest Debt Settlement

Arch Biopartners Inc., announced that the Company has arranged a shares for debt transaction to settle an aggregate of $424,767.07 in interest accrued up to December 31, 2021 on all five of the deferred convertible notes outstanding and disclosed in the Company’s financial statements.

February 8, 2022

·

5 min read

Biotech Beach

BioFluidica Announces $6 Million Series B2 Funding to Support the Commercialization of its Liquid Biopsy Microfluidics Platform, the LiquidScan™, & the Development of its Advanced Handheld Covid-19 Detection Device for Consumer At-Home Testing

BioFluidica, Inc., a biotechnology company developing a diagnostic platform allowing for disease management and diagnosis, announced that it has raised over $6 million in the initial closings of its Series B2 financing.

February 8, 2022

·

3 min read